Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(100.0%)
1Total
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07407673Phase 2Not Yet Recruiting

Prediction and Prevention of Bloodstream Infections After Kidney Transplantation

Role: lead

NCT05604911Active Not Recruiting

Herpes Virus Infections in Kidney Transplant Patients

Role: lead

NCT02382822Active Not Recruiting

Copenhagen Comorbidity in HIV Infection Study

Role: lead

NCT05532540Active Not Recruiting

Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant Study

Role: lead

All 4 trials loaded